Ignite Creation Date:
2024-05-06 @ 5:00 PM
Last Modification Date:
2024-10-26 @ 2:19 PM
Study NCT ID:
NCT05153187
Status:
COMPLETED
Last Update Posted:
2024-04-03
First Post:
2021-11-29
Brief Title:
Real-world Treatment Patterns of Endocrine Based Therapy Among Patients With Hormone Receptor-positiveHuman Epidermal Growth Factor Receptor-2-negative HRHER2- Advanced Breast Cancer An Analysis of Administrative Claims Data in Japan
Sponsor:
Organization:
Pfizer
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
1170
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 81340 |
Who Masked List: